QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
OTCMKTS:TRSSF

TerrAscend (TRSSF) Stock Price, News & Analysis

$1.74
-0.09 (-4.92%)
(As of 04/18/2024 ET)
Today's Range
$1.73
$1.83
50-Day Range
$1.54
$2.18
52-Week Range
$1.62
$1.80
Volume
319,616 shs
Average Volume
131,026 shs
Market Capitalization
$438.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TRSSF stock logo

About TerrAscend Stock (OTCMKTS:TRSSF)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

TRSSF Stock Price History

TRSSF Stock News Headlines

The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
EXCLUSIVE: Why TerrAscend's Success Doesn't Rely On Federal Cannabis Reform
7TRSSF : Why 280e Change Spells Good...
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
TerrAscend (OTC: TRSSF)
TerrAscend (TSX: TSND) Commences Trading on the TSX
TerrAscend Declares its Independence
TerrAscend Secures $20.5M Via Second Tranche Of Private Placements
See More Headlines
Receive TRSSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2021
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Agricultural production - crops
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRSSF
Fax
N/A
Employees
1,125
Year Founded
2017

Profitability

Net Income
$-329,910,000.00
Net Margins
-125.03%
Pretax Margin
-114.03%

Debt

Sales & Book Value

Annual Sales
$247.83 million
Book Value
$1.28 per share

Miscellaneous

Free Float
168,925,000
Market Cap
$438.24 million
Optionable
Not Optionable
Beta
2.89

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jason Garrett Wild R.Ph. (Age 50)
    Exec. Chairman
    Comp: $500k
  • Mr. Ziad Ghanem (Age 45)
    Pres & CEO
    Comp: $587k
  • Mr. Keith Stauffer (Age 53)
    Chief Financial Officer
    Comp: $549.87k
  • Ms. Lynn Gefen (Age 51)
    Chief Legal Officer & Corp. Sec.
    Comp: $394.18k
  • Mr. David Wheeler
    Sr. VP & Chief Information Officer
  • Mr. Matthew Chesler C.F.A.
    Head of Investor Relations
  • Mr. Charles Oster
    Sr. VP of Sales
  • Mr. Jeroen De Beijer
    Chief People & Culture Officer
  • Mr. Jared Anderson
    Sr. VP of Fin. & Strategy
  • Karim Bouaziz
    Pres of the Northeast Region

TRSSF Stock Analysis - Frequently Asked Questions

Should I buy or sell TerrAscend stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TRSSF shares.
View TRSSF analyst ratings
or view top-rated stocks.

How have TRSSF shares performed in 2024?

TerrAscend's stock was trading at $1.63 on January 1st, 2024. Since then, TRSSF stock has increased by 6.7% and is now trading at $1.74.
View the best growth stocks for 2024 here
.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TRSSF) announced its quarterly earnings results on Tuesday, November, 16th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.29. TerrAscend had a negative net margin of 125.03% and a negative trailing twelve-month return on equity of 6.66%.

How do I buy shares of TerrAscend?

Shares of TRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRSSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners